Patents by Inventor Stephanie O'Malley

Stephanie O'Malley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF MGLUR5 ANTAGONISTS FOR TREATING GAMBLING DISORDER
    Publication number: 20240082215
    Abstract: The present invention relates to the use of mavoglurant in the treatment of gambling disorder. The present invention also relates to the use of mavoglurant in the treatment of gaming disorder.
    Type: Application
    Filed: December 9, 2021
    Publication date: March 14, 2024
    Applicants: Novartis AG, Yale University
    Inventors: Fabrizio GASPARINI, Baltazar GOMEZ-MANCILLA, John KRYSTAL, Vincent MALATERRE, Stephanie O'MALLEY, Godfrey PEARLSON, Marc POTENZA
  • Smoking cessation treatments using naltrexone and related compounds
    Patent number: 6541478
    Abstract: Nicotine dependency is treated by administration of an opioid antagonist. In some embodiments, rapid or ultra rapid detoxification techniques include using a combination of an effective amount of an opioid antagonist such as nalmefene, naloxone or naltrexone or a mixture of any one of these, and either clonidine or related compounds either while awake, or while under sedation or anesthesia, followed by continued administration of an effective amount of an opioid antagonist with or without agents that enhance nicotine dependency treatment.
    Type: Grant
    Filed: September 16, 1999
    Date of Patent: April 1, 2003
    Assignee: Yale University
    Inventors: Stephanie O'Malley, Boris Meandzija, Suchitra Krishnan-Sarin
  • Smoking cessation treatments using naltrexone and related compounds
    Patent number: 6004970
    Abstract: Nicotine dependency is treated by administration of an opioid antagonist. In some embodiments, rapid or ultra rapid detoxification techniques include using a combination of an effective amount of an opioid antagonist such as nalmefene, naloxone or naltrexone or a mixture of any one of these, and either clonidine or related compounds either while awake, or while under sedation or anesthesia, followed by continued administration of an effective amount of an opioid antagonist with or without agents that enhance nicotine dependency treatment.
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: December 21, 1999
    Assignee: Yale University
    Inventors: Stephanie O'Malley, Boris Meandzija, Suchitra Krishnan-Sarin, Patrick G. O'Connor